Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
product tampering
professional educational programs, OBRA ‘90
professional judgment
professional malpractice insurance
professional practice considerations authority to dispense prescription drugs collaborative practice agreements conscientious objection emergency contraception (Plan B) prescription refill authorization prescriptive authority Professional Practice Considerations
prohibited acts, penalties, and enforcement mechanisms, FDCA
prospective drug use review, components of Components of Prospective Drug Use Review counseling patients documenting information
prospective review, OBRA ‘90
prosthetics
protected health information (PHI) breach of de-identification of disposal of marketing, sale of permissible use and disclosure of Protected Health Information use and disclosure of
proximate cause
See pharmacy services administrative organizations (PSAOs) Federal Antitrust Laws See pharmacy services administrative organizations (PSAOs) The Sherman Antitrust Act
See patient safety organizations (PSOs) Miscellaneous Federal Laws Related to Pharmacy Practice See patient safety organizations (PSOs) The Patient Safety and Quality Improvement Act of 2005
See patient safety work product (PSWP) See patient safety work product (PSWP) The Patient Safety and Quality Improvement Act of 2005
psyllium
See Patent Term Restoration Act (PTRA) "Paper" New Drug Applications Drug Price Competition and Patent Term Restoration Act of 1984 Historical Overview of the Federal Food, Drug, and Cosmetic Act Importance of the Orange Book in Generic Substitution New Drug Approval Pfizer, Inc. v. Shalala See Patent Term Restoration Act (PTRA)
public comment, regulations
public goods, defined
Public Health Service Act (PHSA) 340B Drugs Expedited Approval of Drugs Intended to Treat Serious or Life-Threatening Illnesses ("Fast Track Approval") (§ 506)
public policy
public registry of clinical trials
punitive damages, malpractice
purchasing cooperatives
Pure Food and Drug Act (1906)
qualified health claim
qualifying practitioner
quality measure
radiopharmaceuticals
Farr (1989) Approved Drugs for Off-Label (Unlabeled) Indications Ramon v. Farr
reasonable safeguards